AUL: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 1''' | |colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 1''' | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black;"| | |colspan="2" style = "font-size:90%; color:black;"|No lineage can be assigned by lineage-defining markers of myeloid, B-lymphoid or T-lymphoid lineage | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 2''' | |colspan="2" style = "font-size:90%; color:black; background:#ddeee1" |'''Requirement 2''' |
Revision as of 18:20, 24 November 2023
.
What features must be met to diagnose acute undifferentiated leukaemia
| |
---|---|
Requirement 1 | |
No lineage can be assigned by lineage-defining markers of myeloid, B-lymphoid or T-lymphoid lineage | |
Requirement 2 | |
No more than one lineage-associated marker for any single lineage is expressed | |
Requirement 3 | |
Ensure that other conditions that may resemble undifferentiated acute leukaemia are excluded: particularly consider: acute megakaryocytic leukaemia, non haematopoietic tumours, blastic plasma dendritic cell neoplasm, and rarely plasma cell leukaemias. |